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Abst ract
Tick-borne encephalitis (TBE) is a disease which may pre-
sent as meningitis, encephalomeningitis and myeloence -
phalomeningitis. The course of the disease is usually mild
although it may result in the patient’s death in 1-4% of cas-
es. Patients with myeloencephalomeningitis are the most
endangered group, but also encephalomeningitis may have
a fatal outcome. There are many risk factors which influence
the severity of TBE, including patient’s age, immunosup-
pression and concomitant diseases. We present four cases of
patients who died because of TBE. The aim of the paper was
to underline that in elderly patients or patients suffering from
chronic diseases and additional infections, special attention
should be paid to their treatment, including mechanical ven-
tilation and steroid use.
Key words: tick-borne encephalitis, sequelae, encephalitis,
fatal outcome.
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CASE REPORT/OPIS PRZYPADKU
St reszc zenie
Kleszczowe zapalenie mózgu (KZM) mo¿e przebiegaæ pod
trzema postaciami: zapalenia opon mózgowo-rdzeniowych,
zapalenia mózgu i opon mózgowo-rdzeniowych oraz zapalenia
rdzenia, mózgu i opon mózgowo-rdzeniowych. Przebieg cho-
roby jest zazwyczaj ³agodny, jednak w przypadku 1–4% pacjen-
tów choroba mo¿e zakoñczyæ siê zgonem. Grupami najbardziej
nara¿onymi na zgon s¹ pacjenci z zapaleniem rdzenia, mózgu
i opon mózgowo-rdzeniowych oraz z zapaleniem mózgu i opon
mózgowo-rdzeniowych. Istnieje wiele czynników wp³ywaj¹cych
na ciê¿koœæ KZM, m.in. wiek pacjentów, upoœledzenie uk³adu
odpornoœciowego i wspó³istnienie innych chorób. W pracy
zaprezentowano opisy czterech przypadków pacjentów, którzy
zmarli z powodu KZM. Celem pracy jest podkreœlenie, i¿
w przypadku starszych pacjentów lub pacjentów z chorobami
przewlek³ymi czy z innymi zaka¿eniami towarzysz¹cymi, 
choruj¹cych na KZM nale¿y zwróciæ uwagê na leczenie, w tym
respiratoro- i steroidoterapiê. 
S³owa kluczowe: kleszczowe zapalenie mózgu, powik³ania,
zapalenie mózgu, zgon.
Introduction 
Tick-borne encephalitis (TBE) virus consists of 
3 sub types: European, Siberian, and Far-Eastern. 
The Si berian and Far-Eastern subtypes are considered to
cause more severe disease than the European subtype [1].
The mortality rate of Far-Eastern subtype infection is 15-
20% versus 1-4% in European subtype infection [1-3].
Recently, TBE has become a growing public health prob-
lem in Europe and other parts of the world [1]. World-
wide, at least 10-12 thousand cases of TBE are reported
each year. What is even more inte resting, the virus is
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spreading to new areas [4-7]. TBE is a relatively frequent
infectious disease in Poland. Data from the National
Health Institute show that on average 250 persons devel-
op symptoms of TBE annually. Most cases are registered
in the North-Eastern part of the country, which is con-
sidered to be an endemic region for TBE [8]. TBE 
presents as meningitis in about 50% of patients, as menin-
goencephalitis in about 40%, and as meningoen-
cephalomyelitis in about 10% [1]. Meningitis is usually
accompanied by high fever, headache, nausea, vomiting
and vertigo. Signs of meningeal irritation usually occur
but may not be pronounced. All patients exhibit cere-
brospinal fluid pleocytosis. Speci fic serological tests are
used in diagnosis. The treatment is symptomatic.
Forest workers and people with a relatively high
work-related risk of acquiring a TBE infection are 
usually vaccinated. The most endangered groups are
elderly people. It is a consequence of their habits, e.g.
collecting mushrooms, leisure activity in forests. Epi-
demiological data from various European countries
demonstrate that the incidence of TBE is higher in
elderly people than in younger age groups. In some
countries (e.g. Germany, Austria, Sweden, Lithuania)
more than 50% of TBE patients are over 50 years old
[9]. In Poland, among 710 patients with TBE hospita -
lized in the Department of Infectious Diseases and Neu-
roinfections in Bia³ystok in 1993-2008, 235 patients
(33%) were > 50 years old.
TBE is a disease with a usually mild course. How-
ever, there may be some risk factors which may lead to
the patient’s death. In this paper, four cases of patients
who died because of TBE are described.
Case reports
Patient 1
A 49-year-old man with a history of tick bite (two
weeks before) was admitted to the Department of Infec-
tious Diseases and Neuroinfections because of severe
headache with vertigo and fever. The symptoms had last-
ed for about two days. 
At admission the patient was conscious. In physical
examination, full neck stiffness and Oppenheim sign
were observed. The cerebrospinal fluid (CSF) exami-
nation revealed inflammatory features (Table 1). Anti-
TBE antibodies in the IgM class were found in serum
and CSF (Table 1). One day after admission dysphagia
and loss of palatal reflexes were observed. The patient
was not able to lift his head. He complained of abdo-
 minal pain. The patient’s history indicated that he had
recently undergone an operation because of pyelonephri-
tis. The next day, despite steroid administration the pa -
tient had high fever (40°C), and dysphagia became more
severe. The patient was transferred to the intensive care
unit (ICU), because of breathing difficulties. 
At admission to the ICU the patient presented with
increasing respiratory failure, nystagmus, ankle clonus,
and Babinski sign. He required mechanical ventilation.
He was treated with antibiotics (cefotaxime 2 g t.i.d.)
and antioedematous drugs (mannitol, dexamethasone).
On the sixth day of therapy, the patient’s state stabiliz -
ed. On the ninth day, severe hyponatraemia was
observed. On the thirteenth day of hospitalization, Guil-
lain-Barré syndrome and polyneuritis were considered.
Control lumbar puncture was performed. In CSF, cyto-
sis and protein concentration were normal (Table 1).
Immu noglobulins were introduced to the therapy. The
steroid daily dosage was increased to 60 mg of pred-
nisone. On the 21st day of hospitalization, treatment with
vancomycin and cefoperazone with sulbactam was
implemented because of positive culture from the res-
piratory tract (MRSA, Acinetobacter baumannii). The pa -
tient underwent intensive physical rehabilitation. He
was also consulted by a psychiatrist (paroxetine was
introduced to the therapy). On the 49th day, the patient
did not require mechanical ventilation and was trans-
ferred to the Department of Neurology.
Despite treatment, his status gradually worsened and
the patient died two months after admission. 
Patient 2
A 70-year-old man with a history of tick bite was
admitted to the Department of Infectious Diseases,
because of headaches and fever for 2 days. He had no
history of any chronic diseases.  
At admission neck stiffness was observed. The CSF
had inflammatory features (Table 1). On the third day
of hospitalization the patient’s general status worsened.
He was disoriented and agitated. There were no abnor-
malities in brain CT. On the fourth day the patient in
comatose state was transmitted to the Department of
Infectious Diseases and Neuroinfections. At admission
the patient had neck stiffness (3 cm) and positive
Kernig’s sign. On the skin of his thigh, scrotum and in
the sacral bone region three ticks were found. Anti-TBE
antibodies in IgM and IgG class in serum and CSF
were present.
Fatal outcome of tick-borne encephalitis
Neurologia i Neurochirurgia Polska 2011; 45, 4404
Patient no. 1 Patient no. 2 Patient no. 3 Patient no. 4
Serological tests
Tick-borne encephalitis (U/mL)*
Serum IgM 300 (positive) 140 (positive) 73 (positive) 200 (positive)
Serum IgG negative 35 (positive) 700 (positive) 40 (positive)
CSF IgM 17 (positive) not examined 50 (positive) not examined
CSF IgG negative not examined 700 (positive) not examined
Borreliosis (BBU/mL)**
Serum IgM 33 (positive) negative negative negative
Serum IgG negative 76 (positive) 56 (positive) negative
CSF IgM negative not examined 10 (positive) not examined
CSF IgG negative not examined 81 (positive) not examined
Plasma/serum
Erythrocyte sedimentation rate [mm/h] 26/52 18 20/70; 30/80 5/12
C-reactive protein [mg/dL] 0.4 – 173.3; 203.7; 133 12.4; 2.4
White blood cell count [1000/mm3] 11.57 8.9; 16.9 16.73; 15.99 5.4; 19.07
Na [mmol/L] 139 136 129 135
K [mmol/L] 4.0 3.85 3.6 4.5
Glucose [mg/dL] 79 100 297; 226 281; 459
Other tests – CK: 942 U/L alkalosis CK: 52 U/L
LDH: 639 U/L D-dimers: LDH: 262 U/L
2195.66 µg/mL AST: 77 U/L
ALT: 77 U/L
CSF
Colour and transparency aqueous, clear aqueous, clear yellow, transparent aqueous, clear
Cytosis [1/mm3] 73; 1 12 310 322
Glucose [mg/dL] 49; 74 67 49 97
Protein [mg/dL] 49.6; 221 52 265.5 49.8
Chloride [mEq/L] 125 120 120 (–)
Nonne-Apelt test (–); (+/–) (–) (+++) (–)
Pandy test (+/–); (+/–) (–) (+++)
Other CSF culture: 
Listeria spp.
Table 1. Results of laboratory tests in reported cases
CSF – cerebrospinal fluid
*Cut-off values: 15 U/mL (IgM), 28 U/ml (IgG) (for serum and CSF)
**Cut-off values (IgM and IgG): 11 BBU/mL (serum), 5 BBU/mL (CSF) 
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On the day of admission respiratory insufficiency
occurred which resulted in the patient’s death. 
Patient 3
A 76-year-old woman was admitted to the Depart-
ment of Infectious Diseases and Neuroinfections with
suspected meningitis. The patient’s history revealed that
two weeks before she had flue-like symptoms: general
weakness and fever.  
At admission her general status was poor; she was
unconscious, without reaction to external stimuli, with
fever (39.8°C). In physical examination, neck stiffness 
(3 cm) and positive Oppenheim sign were found along
with paleness, abnormal breathing sounds in both lung
fields, tachycardia, atrial fibrillation, and hypertension
(180/120, 220/110, 200/100 mm Hg). In laboratory
tests, increased inflammation parameters (leukocytosis,
erythrocyte sedimentation rate, C-reactive protein), alka-
losis, increased D-dimer concentration, hyperglycaemia
and abnormalities in electrolyte concentrations were
observed (Table 1).
The CSF showed inflammatory features (Table 1).
Anti-TBE antibodies and anti-Borrelia burgdorferi in IgM
and IgG class in serum and CSF were found (Table 1).
Antibiotics (rifampicin, amikacin, streptomycin, ceftria -
xone), acyclovir, anti-oedematous drugs (dexamethasone,
mannitol), intravenous fluids, antihypertensive drugs
(captopril, metoprolol) and analgesics were used.  
On the fourth day of hospitalization, the general state
of patient worsened. The patient died because of cardio-
pulmonary insufficiency. In microbiological culture of
CSF acquired after the patient’s death, Listeria spp. were
observed.  
Patient 4
A 73-year-old woman with a history of tick bites was
admitted to the Department of Infectious Diseases
because of headaches, nausea, vomiting, and malaise. At
admission the patient was conscious with slightly
expressed meningeal signs and left upper limb paresis.
In laboratory tests, increased activity of aminotrans-
ferases, inflammation parameters (C-reactive protein),
and hyperglycaemia were observed (Table 1). The CSF
showed inflammatory features (Table 1). Anti-TBE anti-
bodies in serum were found (Table 1).
Despite treatment, the patient’s status worsened.
Right hemiparesis was observed. After a week of thera-
py with ceftriaxone (2 g daily), mannitol (400 ml daily),
and dexamethasone (32 mg daily) the patient was trans-
mitted to the Department of Infectious Diseases and
Neuroinfections. At admission the patient was in a severe
state with limited contact. In physical examination, tachy-
cardia, hypertension, and arrhythmia were revealed, 
as well as Cheyne-Stokes respiration and neck stiffness.
Laboratory tests showed leukocytosis (19 000 per mm3),
hyperglycaemia (459 mg%), and hypoxaemia (67 mm
Hg). Despite intensive insulin therapy, glucose concen-
tration did not decrease. Dyspnoea and tachycardia
became more severe and the patient died at the fifth hour
after admission. 
Discussion
Tick-borne encephalitis is a disease which should be
taken into consideration in every case of encephalitis in
endemic areas. TBE caused by the European virus sub-
type is a disease with a usually mild course. However, it
may take a severe course with fatal outcome in 1-4% of
cases. According to Tomazic et al., fatal outcome occurs
in the acute status of severe encephalitis due to causes that
can be related to direct lesions resulting from the virus in
the CNS. The involvement of vital centres (respiratory,
vasoactive) may also lead to death. The patient in a severe
state is usually treated in the ICU where he/she is addi-
tionally endangered by nosocomial infections [10-12].
According to Pikelj et al., other factors influencing
the course of a TBE infection are early alteration of con-
sciousness (Glasgow Coma Scale score < 7), develop-
ment of limb paralysis together with respiratory insuffi-
ciency within 24-48 hours from the beginning of phase II
of the disease and pleocytosis > 300 cells [13,14].
According to Mickiene et al., a single-phase course of
the disease is also an ominous predictive factor [15]. Late
onset of specific anti-TBE virus IgM antibodies in CSF
is related to the severity of acute encephalitis symptoms. 
In the cases described here, similar risk factors were
observed. Three patients were diagnosed with ence pha -
lomeningitis and one with meningoencepha lomyelitis.
The most common factor which contributed to a severe
course of the disease and death was the patient’s age, as
seen in cases 2, 3, and 4. Also one-phase course of TBE
was present in 3 of the 4 described cases (1, 2, and 4).
Death of 3 patients (2, 3, and 4) occurred in the acute
phase of the disease. In case 1, long-term hospitalization
in the ICU resulted in nosocomial infection, which also
increased the risk of a fatal outcome. In cases 3 and 4,
pleocytosis with >300 cells was present in CSF, although
Neurologia i Neurochirurgia Polska 2011; 45, 4406
in cases 1 and 2 the cell amount was considerably lower.
According to our clinical observations, pleocytosis over
300 cells/mm3 does not correlate with severity of the dis-
ease [8]. Inflammatory indicators do not seem to be rel-
evant for the prediction of the course of the disease,
although they may rise in the acute phase of the disease
(cases 1, 2, and 4). Concomitant chronic diseases seem
to be an important risk factor. Patient 3 suffered from
hypertension and diabetes and patient 4 from diabetes.
Although not described in this paper (not enough data),
it is worth mentioning that a patient also hospitalized in
the Department of Infectious Diseases and Neuroinfec-
tions with diagnosis of TBE died be cause of long-term
(> 10 year) steroid therapy (rheumatoid arthritis). 
In the case of patient 3, coinfection with Listeria
monocytogenes played an important role in the fatal out-
come. Infection with L. monocytogenes alone has a mor-
tality rate of 20%. In this case, TBE was the factor that
lowered the patient’s immunological defence and
enabled L. monocytogenes infection. The result of CSF
culture was acquired after the patient’s death; therefore
no ampicillin treatment was implemented. It has to be
emphasized that the most common coinfection in pa -
tients suffering from TBE is Lyme disease [16]. It is
rarely fatal, but the risk of sequelae seems to be higher
than in patients infected only with TBE virus. 
To sum up, patients who develop encephalitis,
encephalomyelitis, and those with pareses are at high
risk of fatal outcome as a direct consequence. It has to
be emphasized, however, that in the case of elderly
patients or in those suffering from chronic diseases and
additional infections, special attention should be paid to
their treatment, including mechanical ventilation and
steroid therapy. A vaccination programme offered to this
group of people could greatly reduce the risk of fatal
TBE outcome in Poland. 
We conclude that the fatal outcome of TBE may be
a consequence of coexisting risk factors such as age and
concomitant chronic disorders or coinfection, e.g.
L. monocytogenes or others. Pleocytosis may not be used
as a predictive factor of severity of the course of TBE. 
Special efforts should be made to vaccinate elderly
people (> 50 years of age), who constitute the main
group endangered by the development of severe TBE
sequelae. 
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